声明:因水平有限,错误不可避免,或有些信息非最及时,欢迎留言指出。本文仅作医疗健康相关药物介绍,非治疗方案推荐(若涉及);本文不构成任何投资建议。2月25日,赛默飞世尔科学(NYSE: TMO) 宣布已与Solventum(NYSE:SOLV)达成最终协议,以约41亿美元的现金收购Solventum的纯化和过滤业务。该交易预计于2025年底完成。受此交易的影响,赛默飞世尔的股价上涨了 4% ,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.